Skip to main content
Clinical Trials/CTRI/2020/11/029241
CTRI/2020/11/029241
Not yet recruiting
Phase 3

Comparative evaluation of Dexmedetomidine nebulisation and Ketamine nebulisation as an adjuvant to Lignocaine for awake fiberoptic intubation.

King Georges Medical University0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
King Georges Medical University
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
King Georges Medical University

Eligibility Criteria

Inclusion Criteria

  • Patients with American Society of Anaesthesiology grading of 1 and 2\.
  • Patients having Mallampati grading of 3 and 4 and mouth opening less than 2 finger and also patients in whom neck extension is contraindicated.

Exclusion Criteria

  • patients with any type of AV block, bradycardia, hypotension, ventricular dysfunction, heart failure, coronary disease.
  • patients with nasal pathology and recent epistaxis.
  • allergy to drugs being used in the study
  • patients not giving consent

Outcomes

Primary Outcomes

Not specified

Similar Trials